Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis

NCT01732770 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

643

Enrollment

INDUSTRY

Sponsor class

Conditions

Post Menopausal Osteoporosis

Interventions

BIOLOGICAL: Denosumab
DRUG: Zoledronic Acid
DRUG: Placebo to Denosumab
DRUG: Placebo to Zoledronic Acid

Sponsor

Amgen